https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-participate-in-the-biotech-showcase-2022-virtual
https://www.nasdaq.com/press-release/180-life-sciences-corp.-enters-into-a-license-agreement-with-university-of-oxford-for
https://www.nasdaq.com/press-release/180-life-sciences-provides-follow-up-information-on-oxford-university-and-the
https://www.nasdaq.com/press-release/180-life-sciences-corp.-co-founder-prof.-jagdeep-nanchahal-presents-keynote-address
https://www.nasdaq.com/press-release/180-life-sciences-corp.-expands-patent-portfolio-2021-11-22
https://www.nasdaq.com/press-release/180-life-sciences-corp.-co-founder-prof.-jagdeep-nanchahal-to-present-a-keynote
https://www.nasdaq.com/press-release/180-life-sciences-corp.-names-quan-a.-vu-chief-operating-officer-chief-business
https://www.nasdaq.com/press-release/180-life-sciences-corp.-publishes-pre-clinical-study-report-on-the-effects-of-cbg
https://www.nasdaq.com/press-release/180-life-sciences-corp.-continues-to-expand-intellectual-property-portfolio-2021-09
https://www.nasdaq.com/press-release/celltrion-healthcare-and-180-life-sciences-enter-into-memorandum-of-understanding-for
https://www.nasdaq.com/press-release/180-life-sciences-corp.-ceo-james-woody-md-phd-issues-letter-to-stockholders-2021-08
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-closing-of-%2415.0-million-private-placement-2021-08
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-%2415.0-million-private-placement-2021-08-19
https://www.nasdaq.com/press-release/chairman-of-the-180-life-sciences-clinical-advisory-board-professor-jagdeep-nanchahal
https://www.nasdaq.com/press-release/180-life-sciences-to-participate-in-fireside-chat-at-btig-virtual-biotechnology
https://www.nasdaq.com/press-release/180-life-sciences-announces-selection-of-lead-synthetic-cbd-analogue-2021-07-28
https://www.nasdaq.com/press-release/180-life-sciences-regains-nasdaq-compliance-under-listing-rule-5250c1-2021-07-20
https://www.nasdaq.com/press-release/180-life-sciences-regains-nasdaq-compliance-for-listing-rules-5605b1-and-5605c2-2021
https://www.nasdaq.com/press-release/180-life-sciences-expands-scientific-fibrosis-platform-with-collagen-vi-as-a-driver
https://www.nasdaq.com/press-release/180-life-sciences-joins-russell-microcapr-index-2021-06-28
https://www.nasdaq.com/press-release/180-life-sciences-files-plan-with-nasdaq-related-to-delayed-quarterly-report-on-form
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-the-appointment-of-pamela-marrone-phd-and-frank
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-ld-micro-invitational-xi-2021-06-01
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-the-appointment-of-russell-t.-ray-mba-and-teresa
https://www.nasdaq.com/press-release/180-life-sciences-corp.-receives-expected-notification-from-nasdaq-related-to-0
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-collection-of-all-patient-data-for-phase-2b
https://www.nasdaq.com/press-release/180-life-sciences-corp.-receives-expected-notification-from-nasdaq-related-to-delayed
https://www.nasdaq.com/press-release/180-life-sciences-corp.-congratulates-dr.-lynn-williams-on-international-dupuytren
https://www.nasdaq.com/press-release/180-life-sciences-corp.-nasdaq%3a-atnf-recognized-rd-pioneers-in-anti-inflammatory
https://www.nasdaq.com/press-release/180-life-sciences-corp.-nasdaq%3a-atnf-in-hot-pursuit-of-new-anti-inflammatory
https://www.nasdaq.com/press-release/180-life-sciences-corp.-ceo-james-woody-md-phd-issues-letter-to-stockholders-2021-03
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-inaugural-emerging-growth-virtual-conference
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-closing-of-%2411.7-million-private-placement-2021-02
https://www.nasdaq.com/press-release/180-life-sciences-corp.-announces-%2411.7-million-private-placement-2021-02-19
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-the-biotech-showcasetm-digital-2021-conference
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-the-h.c.-wainwright-bioconnect-2021-conference
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-present-at-the-13th-annual-ld-micro-main-event-conference
https://www.nasdaq.com/press-release/180-life-sciences-corp.-to-ring-nasdaq-opening-bell-on-november-27-2020-2020-11-24
https://www.nasdaq.com/press-release/180-life-sciences-corp.-continues-to-expand-intellectual-property-portfolio-with
https://www.nasdaq.com/press-release/180-life-sciences-corp.-ceo-james-woody-md-phd-issues-letter-to-stockholders-2020-11
https://www.nasdaq.com/press-release/180-life-sciences-announces-completion-of-transaction-with-kblm-merger-corp-iv-2020
https://www.nasdaq.com/press-release/kbl-merger-corp.-iv-announces-approval-of-business-combination-with-180-life-sciences
https://www.nasdaq.com/press-release/innovative-companies-with-blockbuster-potential-catch-spac-attention-2020-10-23
https://www.nasdaq.com/press-release/kbl-merger-corp.-iv-announces-change-of-special-meeting-of-shareholders-date-to
https://www.nasdaq.com/press-release/update-the-quest-for-blockbuster-drugs-continues-2020-10-21
https://www.nasdaq.com/press-release/promising-biotechs-choosing-spac-for-speed-capital-visibility-2020-10-14
https://www.nasdaq.com/press-release/180-life-sciences-corp.-expands-intellectual-property-portfolio-2020-10-06
https://www.nasdaq.com/press-release/development-of-next-generation-drugs-to-inhibit-ravages-of-chronic-inflammation-2020
